HomeTargets › p38α MAPK

p38α MAPK (1 companies · 2 programs)

Companies with an active program directed at p38α MAPK.

CervoMed Inc. CRVO

  • neflamapimod — Dementia with Lewy Bodies Phase 2
  • neflamapimod — Frontotemporal Dementia